About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Stereotactic Radiotherapy for Sinonasal Malignancy | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT06617910

Stereotactic Radiotherapy for Sinonasal Malignancy

Sinonasal Tumors are a rare type of head and neck tumor, accounting for approximately 3% of head and neck cancers. Treatment primarily involves surgical intervention, with radiation therapy as an adju...

Lead sponsor: Taichung Veterans General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Taichung Veterans General Hospital

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The pathological tissue report from the endoscopic surgery at this hospital confirmed a diagnosis of malignant sinus tumor.
•Received radical stereotactic radiotherapy at this hospital.
•Pre-treatment baseline imaging (CT or MRI) was performed.
•Received radical radiotherapy at this hospital and has been under long-term follow-up with complete medical records at this hospital.

Exclusion Criteria

•Local lymphatic metastasis and distant metastasis have been excluded by imaging examinations (cN \&gt;=1, M =1).
•Not treated with radical radiotherapy at this hospital and has been under long-term follow-up at this hospital with incomplete medical records.

Related studies

Biospecimen Procurement for Head and Neck Disorders

NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more

Molecular and Genomic Profiling of Head and Neck Tumors

NCT00200486 · Head and Neck Neoplasms

RECRUITINGPhase 2

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

NCT05544136 · Head and Neck Cancer, Head and Neck Carcinoma, and more

RECRUITINGPhase 3

Head and Neck Cancer Study Project in the Geriatric Population

NCT06998069 · Head and Neck Neoplasms

RECRUITINGPhase 1

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

NCT06912087 · Head and Neck Neoplasms, Carcinoma, Squamous Cell, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment16

Start dateSep 2023

Last updatedOct 1, 2024

Condition

Head and Neck Neoplasms

Locations shown

Taichung Veterans General Hospital

Taichung

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions